ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Singing to support VHIO’s research programs of excellence: Spanish rock star Pau Donés takes center stage

07/11/2018|Comments Off on Singing to support VHIO’s research programs of excellence: Spanish rock star Pau Donés takes center stage

U.S. Department of Defense supports dedicated program to more precisely match medicines against prostate cancer

05/11/2018|Comments Off on U.S. Department of Defense supports dedicated program to more precisely match medicines against prostate cancer

Swiss Bridge Foundation awards VHIO’s Rodrigo A. Toledo as ‘propeller’ of IMMUNOMICS-driven cancer discovery

30/10/2018|Comments Off on Swiss Bridge Foundation awards VHIO’s Rodrigo A. Toledo as ‘propeller’ of IMMUNOMICS-driven cancer discovery

Congress 2018 TV: ESMO’s President and President-Elect on the surveying surrounding this year’s ESMO Congress theme, some next step directions and a few meeting ‘take-homes’

29/10/2018|Comments Off on Congress 2018 TV: ESMO’s President and President-Elect on the surveying surrounding this year’s ESMO Congress theme, some next step directions and a few meeting ‘take-homes’

See all news

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO´s Scientific Committee headed by José Baselga. A total of 25 renowned Principal Investigators manage and run VHIO´s major research themes and programs.

BROWSE OUR PIs
Launch our Scientific Report 2016

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
BBVA FOUNDATION’s IMMUNOTHERAPY
& IMMUNOLOGY PROGRAM (CAIMI)
OBRA SOCIAL “LA CAIXA”
INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

FEATURED EVENT 2019
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS